| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-09 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |